4. Bibliografía

Adachi Y, Lee CT, Coffee K, Yamagata N, Ohm JE, Park KH, Dikov MM, Nadaf SR, Arteaga CL, Carbone DP. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines.Gastroenterology 2002;123(4):1191-204.

Adams TE, Mckern NM, Ward CW. Signalling by the type 1 Insulin-like growth factor receptor: Interplay with the epidermal growth factor receptor. Growth Factors 2004; 22(2):89-95.

Ahlén J, Wejde J, Brosjö O, von Rosen A, Weng WH, Girnita L, Larsson O, Larsson C. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.Clin Cancer Res 2005;11(1):206-16.

Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, Kim DS, Lee JH. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 2001; 81(3):341-7.

Baserga R. The IGF-I receptor in cancer research. Exp Cell Res 1999; 253(1):1-6.

Caputi M, Groeger AM, Esposito V, Dean C, De Luca A, Pacilio C, Muller MR, Giordano GG, Baldi F, Wolner E, Giordano. A prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol1999; 20(4):746-50.

Cheung TH, Yu MM, Lo KW, Yim SF, Chung TK, Wong YF. Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett 2001; 166(2):199-206.

Chinnaiyan P, Allen GW, Harari PM. Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras.Semin Radiat Oncol 2006; 16(1):59-64. Review.

Cho NH, Kim YT, Kim JW. Correlation between G1 cyclins and HPV in the uterine cervix. Int J Gynecol Pathol 1997; 16(4):339-47.

Cosaceanu D, Carapancea M, Castro J, Ekedahl J, Kanter L, Lewensohn R, Dricu A. Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation. Cancer Letters 2005; 222(2):173-81.

Cosaceanu D, Budiu RA, Carapancea M, Castro J, Lewensohn R, Dricu A. Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by

cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.Mol Cell Endocrinol 2005;229(1-2):161-73.

Michalides RJ, Van veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ, Balm AJ. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1997; 123(5):497-502.

Nakamura M, Miyamoto S, Maeda H, Zhang SC, Sangai T, Ishii G, Hasebe T, Endoh Y, Saito N, Asaka M, Ochiai A. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes'C human colorectal cancers.Clin Cancer Res 2004;10(24):8434-41.

Navarro, Baserga. Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor. Endocrinology 2001; 142(3):1073-81.

Perer ES, Madan AK, Shurin A, Zakris E, Romeguera K, Pang Y, Beech DJ. Insulin-like growth factor I receptor antagonism augments response to chemoradiation therapy in colon cancer cells. Surg Res 2000;94(1):1-5.

Peretz S, Jensen R, Baserga R, Glazer PM. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc Natl Acad.Sci USA 2001; 98(4):1676-81.

Peters G, Gongoll S, Langner C, Mengel M, Piso P, Klempnauer J, Ruschoff J, Kreipe H, von Wasielewski R. IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer.Virchows Arch 2003;443(2):139-45. Epub 2003 Jul 5.

Railo MJ, von Smitten K, Pekonen F.The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients. Eur J Cancer 1994; 30A(3):307-11.

Reinmuth N, Liu W, Fan F, Jung YD, Ahmad SA, Stoeltzing O, Bucana CD, Radinsky R, Ellis LM. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. Clin Cancer Res 2002; 8(10):3259-69.

Shen MR, Hsu YM, Hsu KF, Chen YF, Tang MJ, Chou CY. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.Carcinogenesis 2006; 27(5):962-71. Epub 2006 Jan 7.

Shimizu C, Hasegawa T, Tani Y, Takahashi F, Takeuchi M, Watanabe T, Ando M, Katsumata N, Fujiwara Y. Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.Hum Pathol 2004;35(12):1537-42.

Shiohara S, Shiozawa T, Miyamoto T, Feng YZ, Kashima H, Kurai M, Suzuki A,Konishi I. Expression of cyclins, p53, and ki-67 in cervical squamous cell

interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism. Oncogene 2006; [Epub ahead of print] .

Coskun U, Gunel N, Sancak B, Gunel U, Onuk E, Bayram O, Yilmaz E, Candan S, Ozkan S. Significance of serum vascular endotelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients. Breast 2003; 12(2):104-10.

Girnita L, Girnita A, Larsson O. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci USA 2003; 100(14):8247-52.

Gray SG, Stenfeldt Mathiasen I, de Meyts P. The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy? Horm Metab Res 2003; 35 (11-12):857-71.

Hirano S, Ito N, Takahashi S, Tamaya T. Clinical implications of insulin-like growth factors through the presence of their binding proteins and receptors expressed in gynaecological cancers. Eur J Gynaecol Oncol 2004; 25(2):187-91.

Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annu Rev Biochem 2000; 69:373-98.

Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A, Ogoshi S. Cyclin: D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 1998; 77(1):92-7.

Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 1997; 17(3):1595-606.

Lin J, Adam RM, Santiestevan E, Freeman MR. The phosphatidylinositol 3’-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCap human prostate carcinoma cells. Cancer Res 1999; 59(12):2891-7.

Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky NI, Shiloh Y, Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhaced radiosensitivity and impaired activation of Atm kinase. Oncogene 2001; 20(30):4029-40.

Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ, Sarcevic B. Estrogen and insulin/IGF-1

carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.Virchows Arch.2005;446(6):626-33.

Skomedal H, Kristensen GB, Lie AK, Holm R. Aberrant Expresión of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, Rb, and EGFR in cervical carcinomas. Gynecol Oncol;1999;73(2):223-8.

Skomedal H, Forus A, Holm R. Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer. Anticancer Res 2003; 23(5A):3929-35.

Southern SA, Herrington CS. Differential cell cycle regulation by low-and high–risk human papillomaviruses in low-grade squamous intraepithelial lesions of the cervix. Cancer Res 1998; 58: 2941-45.

Steller MA, Delgado CH, Bartels CJ, Woodworth CD, Zou Z. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in Human cervical cancer cells. Cancer Res 1996; 56(8):1761-5.

Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM. Regulation of hypoxia inducible factor-1 alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am.J Pathol 2003; 163(3):1001-11.

Stull MA, Richert MM, Loladze AV, Wood TL. Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells. Endocrinology 2002; 143:1872-9.

Suzuki Y, Nakano T, Kato S, Ohno T, Tsujii H, Oka K. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis. Int J Radiat Oncol Biol Phys 2004; 60(1):231-6.

Wen B, Deutsch E, Marangoni E, Frascona V, Maggiorella L, Abdulkarim. Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells. Br J cancer 2001; 85(12):2017-21.

Werner H, Shalita-Chesner M, Abramovitch S, Idelman G, Shaharabanigargir L, Glaser T. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab 2000; 71(1-2):315-20.

Zhang X, Lin M, van Golen KL, Yoshioka K, Itoh K, Yee D. Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration.Breast Cancer Res Treat 2005; 93(2):159-68.

Zhao H, Dupont J, Yakar S, Karas M, LeRoith D.PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells.Oncogene 2004;23(3):786-94.